C. Niveaux-de-résistance,

L. L. Judd, H. S. Akiskal, P. J. Schettler, J. Endicott, J. Maser et al., The long-term natural history of the weekly symptomatic status of bipolar I disorder, Arch Gen Psychiatry. juin, vol.59, issue.6, pp.530-537, 2002.

S. H. Poon, K. Sim, M. Y. Sum, C. N. Kuswanto, and R. J. Baldessarini, Evidence-based options for treatment-resistant adult bipolar disorder patients, Bipolar Disorders. 1 sept, vol.14, issue.6, pp.573-84, 2012.

M. Fornaro, F. Iasevoli, S. Novello, A. Fusco, A. A. et al., Predictors of hospitalization length of stay among re-admitted treatment-resistant Bipolar Disorder inpatients, Journal of Affective Disorders. 1 mars, vol.228, pp.118-142, 2018.

G. S. Sachs, . Treatment-resistant-bipolar, and . Depression, Psychiatric Clinics of North America. 1 juin, vol.19, issue.2, pp.215-251, 1996.

L. N. Yatham, J. R. Calabrese, and V. Kusumakar, Bipolar depression: criteria for treatment selection, definition of refractoriness, and treatment options, Bipolar Disorders. 1 avr, vol.5, issue.2, pp.85-97, 2003.

M. Gitlin, Treatment-resistant bipolar disorder, Molecular psychiatry, vol.11, issue.3, p.227, 2006.

I. Pacchiarotti, L. Mazzarini, F. Colom, J. Sanchez-moreno, P. Girardi et al., Treatment-resistant bipolar depression: towards a new definition, Acta Psychiatrica Scandinavica. 1 déc, vol.120, issue.6, pp.429-469, 2009.

L. L. Judd, P. J. Schettler, H. S. Akiskal, W. Coryell, A. C. Leon et al., Residual Symptom Recovery From Major Affective Episodes in Bipolar Disorders and Rapid Episode Relapse/Recurrence, Arch Gen Psychiatry. 1 avr, vol.65, issue.4, pp.386-94, 2008.

A. Cleare, A Multidimensional Tool to Quantify Treatment Resistance in Depression: The Maudsley Staging Method, J Clin Psychiatry. 27 janv, vol.70, issue.2, pp.177-84, 2009.

A. J. Rush, M. H. Trivedi, S. R. Wisniewski, A. A. Nierenberg, J. W. Stewart et al., Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report, Am J Psychiatry, vol.163, issue.11, pp.1905-1922, 2006.

Y. Lakshmi, N. , K. Sidney, H. , P. Sagar et al., Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder, Bipolar Disorders. 14 mars, vol.20, issue.2, pp.97-170, 2018.

B. Motovsky and J. Pecenak, Psychopathological characteristics of bipolar and unipolar depression -potential indicators of bipolarity, Psychiatr Danub. mars, vol.25, issue.1, pp.34-43, 2013.

J. Almeida, . De, and M. L. Phillips, Distinguishing between Unipolar Depression and Bipolar Depression: Current and Future Clinical and Neuroimaging Perspectives, Biological Psychiatry. 15 janv, vol.73, issue.2, pp.111-119, 2013.

D. J. Bond, M. M. Noronha, M. Kauer-sant'anna, R. W. Lam, and L. N. Yatham, Antidepressantassociated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis, J Clin Psychiatry, vol.69, issue.10, pp.1589-601, 2008.

I. Pacchiarotti, D. J. Bond, R. J. Baldessarini, W. A. Nolen, H. Grunze et al., The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders, Am J Psychiatry. nov, vol.170, issue.11, pp.1249-62, 2013.

J. Garrabé, Remarques historiques sur la nosographie des troubles thymiques : de la psychose maniaco-dépressive à la bipolarité. Annales Médico-psychologiques, revue psychiatrique, vol.172, pp.642-51, 2014.

M. Schou and . Normothymotics, Mood-Normalizers": Are Lithium and the Imipramine Drugs Specific for Affective Disorders? The British Journal of Psychiatry, vol.109, pp.803-812, 1963.

M. S. Bauer and L. Mitchner, What is a « mood stabilizer »? An evidence-based response, Am J Psychiatry. janv, vol.161, issue.1, pp.3-18, 2004.
DOI : 10.1176/appi.ajp.161.1.3

M. Alda, P. Grof, G. A. Rouleau, G. Turecki, and L. T. Young, Investigating responders to lithium prophylaxis as a strategy for mapping susceptibility genes for bipolar disorder, Progress in Neuro-Psychopharmacology and Biological Psychiatry. 1 juill, vol.29, issue.6, pp.1038-1083, 2005.

H. Grunze, E. Vieta, G. M. Goodwin, C. Bowden, R. W. Licht et al., The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression, World J Biol Psychiatry. mars, vol.11, issue.2, pp.81-109, 2010.

C. B. Nemeroff, D. L. Evans, L. Gyulai, G. S. Sachs, C. L. Bowden et al., Double-Blind, Placebo-Controlled Comparison of Imipramine and Paroxetine in the Treatment of Bipolar Depression, AJP. 1 juin, vol.158, issue.6, pp.906-918, 2001.

F. K. Goodwin, D. L. Murphy, and W. E. Bunney, Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study. Arch Gen Psychiatry, vol.21, pp.486-96, 1969.
DOI : 10.1001/archpsyc.1969.01740220102012

F. K. Goodwin, D. L. Murphy, D. L. Dunner, and W. E. Bunney, Lithium Response in Unipolar Versus Bipolar Depression, AJP. 1 juill, vol.129, issue.1, pp.44-51, 1972.

M. Baron, E. S. Gershon, R. V. Jonas, W. Z. Buchsbaum, and M. , Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-Omethyl transferase, and family history, Arch Gen Psychiatry. sept, vol.32, issue.9, pp.1107-1118, 1975.
DOI : 10.1001/archpsyc.1975.01760270039003

A. J. Gelenberg, J. A. Carroll, M. G. Baudhuin, J. W. Jefferson, and J. H. Greist, The meaning of serum lithium levels in maintenance therapy of mood disorders: a review of the literature, J Clin Psychiatry. déc, vol.50, pp.45-47, 1989.

M. Schou,

, Encephale. avr, vol.26, issue.2, pp.1-6, 2000.

J. R. Calabrese, R. F. Huffman, R. L. White, S. Edwards, T. R. Thompson et al., Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials, Bipolar Disord. mars, vol.10, issue.2, pp.323-356, 2008.

J. R. Geddes, J. R. Calabrese, and G. M. Goodwin, Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials, Br J Psychiatry. janv, vol.194, issue.1, pp.4-9, 2009.

T. Suppes, L. B. Marangell, I. H. Bernstein, D. I. Kelly, E. G. Fischer et al., A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression, J Affect Disord. déc, vol.111, issue.2-3, pp.334-377, 2008.

D. Vervloet,

, Rev Mal Respir. févr, vol.19, issue.1, pp.29-32, 2002.

K. Li, J. Tao, Y. Li, M. Chen, X. Wu et al., Patterns of persistence with pharmacological treatment among patients with current depressive episode and their impact on long-term outcome: a naturalistic study with 5-year follow-up, Patient Prefer Adherence, vol.12, pp.681-93, 2018.

F. Colom, Achieving remission and recovery in bipolar disorder, J Clin Psychiatry, vol.71, issue.11, p.32, 2010.

P. E. Keck, S. L. Mcelroy, S. M. Strakowski, M. L. Bourne, and S. A. West, Compliance with maintenance treatment in bipolar disorder, Psychopharmacol Bull, vol.33, issue.1, pp.87-91, 1997.

C. Schumann, G. Lenz, A. Berghöfer, and B. Müller-oerlinghausen, Non-adherence with longterm prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients, Psychiatry Research. déc, vol.89, issue.3, pp.247-57, 1999.

B. L. Haynes, Promoting Compliance When Faith Gets in the Way, J Christ Nurs. juin, vol.34, issue.2, pp.112-121, 2017.

K. Thompson, J. Kulkarni, and A. A. Sergejew, Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses, Schizophrenia Research. 5 mai, vol.42, issue.3, pp.241-248, 2000.

S. De-geest and E. Sabaté, Adherence to long-term therapies: evidence for action, Eur J Cardiovasc Nurs. déc, vol.2, issue.4, p.323, 2003.

D. Velligan, M. Sajatovic, M. Valenstein, W. T. Riley, S. Safren et al., Methodological challenges in psychiatric treatment adherence research, Clin Schizophr Relat Psychoses. avr, vol.4, issue.1, pp.74-91, 2010.

E. Leclerc, R. B. Mansur, and E. Brietzke, Determinants of adherence to treatment in bipolar disorder: A comprehensive review, Journal of Affective Disorders. 1 juill, vol.149, issue.1, pp.247-52, 2013.

J. L. Strauss and S. L. Johnson, Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms, Psychiatry Res. 7 déc, vol.145, issue.2-3, pp.215-238, 2006.

M. Maurel, J. Azorin, M. Adida, E. Fakra, R. Richieri et al.,

. Encephale and . Déc, , vol.36, pp.202-205, 2010.

M. Lolich, G. H. Vázquez, L. M. Alvarez, and J. M. Tamayo, Psychosocial interventions in bipolar disorder: a review, Actas Esp Psiquiatr. avr, vol.40, issue.2, pp.84-92, 2012.

D. Schrenk, D. Brockmeier, K. Mörike, K. W. Bock, and M. Eichelbaum, A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers, Eur J Clin Pharmacol. janv, vol.53, issue.5, pp.361-368, 1998.

C. B. Eap, S. Bender, J. Sirot, E. Cucchia, G. Jonzier-perey et al., Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene, J Clin Psychopharmacol. avr, vol.24, issue.2, pp.214-223, 2004.

V. Ozdemir, W. Kalow, A. B. Okey, M. S. Lam, L. J. Albers et al., Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine, J Clin Psychopharmacol. déc, vol.21, issue.6, pp.603-610, 2001.

T. Haslemo, P. H. Eikeseth, L. Tanum, E. Molden, and H. Refsum, The effect of variable cigarette consumption on the interaction with clozapine and olanzapine, Eur J Clin Pharmacol. déc, vol.62, issue.12, pp.1049-53, 2006.

M. S. Faber and U. Fuhr, Time response of cytochrome P450 1A2 activity on cessation of heavy smoking, Clin Pharmacol Ther. août, vol.76, issue.2, pp.178-84, 2004.

S. Quaranta, J. Dupouey, R. Colle, and C. Verstuyft, Pharmacogénétique des médicaments antidépresseurs : état des connaissances et des pratiques -recommandations du Réseau national de pharmacogénétique (RNPGx), Thérapie. 1 avr, vol.72, issue.2, pp.301-310, 2017.

J. Kirchheiner, K. Nickchen, M. Bauer, M. Wong, J. Licinio et al., Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response, Mol Psychiatry. mai, vol.9, issue.5, pp.442-73, 2004.

T. Rau, G. Wohlleben, H. Wuttke, N. Thuerauf, J. Lunkenheimer et al., CYP2D6 genotype: impact on adverse effects and nonresponse during treatment with antidepressants-a pilot study, Clin Pharmacol Ther. mai, vol.75, issue.5, pp.386-93, 2004.

A. Nordenskjöld, ECT is superior to pharmacotherapy for the short-term treatment of medication-resistant inpatients with bipolar depression. Evidence Based Mental Health, vol.18, pp.118-118, 2015.

G. Perugi, P. Medda, C. Toni, M. G. Mariani, C. Socci et al., The Role of Electroconvulsive Therapy (ECT) in Bipolar Disorder: Effectiveness in 522 Patients with Bipolar Depression, Mixed-state, Mania and Catatonic Features, Curr Neuropharmacol. avr, vol.15, pp.359-71, 2017.

D. J. Miklowitz and M. W. Otto, Psychosocial interventions for bipolar disorder: a review of literature and introduction of the systematic treatment enhancement program, Psychopharmacol Bull, vol.40, issue.4, pp.116-147, 2007.

S. Salcedo, A. K. Gold, S. Sheikh, P. H. Marcus, A. A. Nierenberg et al., Empirically supported psychosocial interventions for bipolar disorder: Current state of the research, J Affect Disord, vol.01, pp.203-217, 2016.

M. L. Chatterton, E. Stockings, M. Berk, J. J. Barendregt, R. Carter et al., Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: network meta-analysis, Br J Psychiatry, vol.210, issue.5, pp.333-374, 2017.

K. R. Merikangas, H. S. Akiskal, J. Angst, P. E. Greenberg, R. Hirschfeld et al., Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication, Arch Gen Psychiatry. mai, vol.64, issue.5, pp.543-52, 2007.

J. Kahn,

, Encephale. sept, vol.32, pp.511-514, 2006.

J. Mcdermid, J. Sareen, R. El-gabalawy, J. Pagura, R. Spiwak et al., Co-morbidity of bipolar disorder and borderline personality disorder: findings from the National Epidemiologic Survey on Alcohol and Related Conditions, Compr Psychiatry. avr, vol.58, pp.18-28, 2015.

G. E. Hunt, G. S. Malhi, M. Cleary, H. Lai, and T. Sitharthan, Comorbidity of bipolar and substance use disorders in national surveys of general populations, 1990-2015: Systematic review and meta-analysis, J Affect Disord, vol.206, pp.321-351, 2016.

A. Schaffer, E. T. Isometsä, L. Tondo, D. Moreno, G. Turecki et al., International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder, Bipolar Disord. févr, vol.17, issue.1, pp.1-16, 2015.

F. Cassidy, E. P. Ahearn, and B. J. Carroll, Substance abuse in bipolar disorder, Bipolar Disord. août, vol.3, issue.4, pp.181-189, 2001.

E. J. Dalton, C. Td, E. Mundo, S. V. Parikh, and J. L. Kennedy, Suicide risk in bipolar patients: the role of co-morbid substance use disorders, Bipolar Disord. févr, vol.5, issue.1, pp.58-61, 2003.

T. Treuer and M. Tohen, Predicting the course and outcome of bipolar disorder: A review, 2010.

D. Sur,

J. H. Lee and D. L. Dunner, The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders, Depress Anxiety, vol.25, issue.2, pp.91-98, 2008.

F. Benazzi, Borderline personality-bipolar spectrum relationship, Prog Neuropsycho pharmacol Biol Psychiatry. janv, vol.30, issue.1, pp.68-74, 2006.

J. Paris, J. Gunderson, and I. Weinberg, The interface between borderline personality disorder and bipolar spectrum disorders, Compr Psychiatry. avr, vol.48, issue.2, pp.145-54, 2007.

R. Alesiani, S. Boccalon, L. Giarolli, N. Blum, and A. Fossati, Systems Training for Emotional Predictability and Problem Solving (STEPPS): program efficacy and personality features as predictors of drop-out -an Italian study, Compr Psychiatry. mai, vol.55, issue.4, pp.920-927, 2014.

M. J. Brus, M. V. Solanto, and J. F. Goldberg, Adult ADHD vs. bipolar disorder in the DSM-5 era: a challenging differentiation for clinicians, J Psychiatr Pract, vol.20, issue.6, pp.428-465, 2014.

H. G. Ruhé, G. Van-rooijen, J. Spijker, F. Peeters, and A. H. Schene, Staging methods for treatment resistant depression. A systematic review, Journal of Affective Disorders. 1 mars, vol.137, issue.1, pp.35-45, 2012.

A. Fekadu, S. C. Wooderson, K. Markopoulou, and A. J. Cleare, The Maudsley Staging Method for treatment-resistant depression: prediction of longer-term outcome and persistence of symptoms, J Clin Psychiatry. juill, vol.70, issue.7, pp.952-959, 2009.

A. Fekadu, L. J. Rane, S. C. Wooderson, K. Markopoulou, L. Poon et al., Prediction of longer-term outcome of treatment-resistant depression in tertiary care, Br J Psychiatry, vol.201, issue.5, pp.369-75, 2012.

A. Fekadu, J. G. Donocik, and A. J. Cleare, Standardisation framework for the Maudsley staging method for treatment resistance in depression, BMC Psychiatry. 11 avr, vol.18, issue.1, p.100, 2018.

F. Peeters, H. G. Ruhe, M. Wichers, L. Abidi, K. Kaub et al., The Dutch Measure for quantification of Treatment Resistance in Depression (DM-TRD): an extension of the Maudsley Staging Method, Journal of Affective Disorders, vol.205, pp.365-71, 2016.

S. M. Van-belkum, H. H. Geugies, T. S. Lysen, A. J. Cleare, F. Peeters et al., Validity of the Maudsley Staging Method in Predicting Treatment-Resistant Depression Outcome Using the Netherlands Study of Depression and Anxiety, J Clin Psychiatry. 23 janv, vol.79, issue.1, 2018.

A. M. Frank, T. R. Mcconnell, E. S. Rawson, and A. Fradkin, Clinical and functional predictors of health-related quality of life during cardiac rehabilitation, J Cardiopulm Rehabil Prev. août, vol.31, issue.4, pp.223-232, 2011.

C. E. Verboom, J. Ormel, W. A. Nolen, B. Penninx, and J. J. Sijtsema, Moderators of the synchrony of change between decreasing depression severity and disability, Acta Psychiatrica Scandinavica. 1 sept, vol.126, issue.3, pp.175-85, 2012.

C. E. Verboom, M. Sentse, J. J. Sijtsema, W. A. Nolen, J. Ormel et al., Explaining heterogeneity in disability with major depressive disorder: Effects of personal and environmental characteristics, Journal of Affective Disorders. 1 juill, vol.132, issue.1, pp.71-81, 2011.